Register entry

Amicus Therapeutics US, LLC

Registered sites
0
Drug products
3
Live patents
75
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

75

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
GALAFOLDMIGALASTAT HYDROCHLORIDEMay 2027
GALAFOLDMIGALASTAT HYDROCHLORIDEApr 2028
GALAFOLDMIGALASTAT HYDROCHLORIDEFeb 2029
GALAFOLDMIGALASTAT HYDROCHLORIDEOct 2031
GALAFOLDMIGALASTAT HYDROCHLORIDEJul 2036
GALAFOLDMIGALASTAT HYDROCHLORIDEMar 2037
GALAFOLDMIGALASTAT HYDROCHLORIDEMay 2038
GALAFOLDMIGALASTAT HYDROCHLORIDEAug 2038
GALAFOLDMIGALASTAT HYDROCHLORIDEFeb 2039
GALAFOLDMIGALASTAT HYDROCHLORIDEFeb 2039
GALAFOLDMIGALASTAT HYDROCHLORIDEFeb 2039
GALAFOLDMIGALASTAT HYDROCHLORIDEMar 2039
GALAFOLDMIGALASTAT HYDROCHLORIDEMar 2039
GALAFOLDMIGALASTAT HYDROCHLORIDEMay 2041
GALAFOLDMIGALASTAT HYDROCHLORIDEJan 2042
OPFOLDAMIGLUSTATMar 2033
OPFOLDAMIGLUSTATSept 2035
OPFOLDAMIGLUSTATDec 2036
OPFOLDAMIGLUSTATAug 2037
OPFOLDAMIGLUSTATSept 2038
Catalogue

Marketed products

3

Showing 3 of 3.

BrandGeneric nameFormCategory
Galafoldmigalastat hydrochlorideCAPSULENDA
OPFOLDAmiglustatCAPSULENDA
POMBILITI ATGAcipaglucosidase alfa-atgaINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONBLA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.